Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: The Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni in Patients With Type II Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating cardiovascular and renal effects of Moringa oleifera extracts and Stevia rebaudiana in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moringa oleifera extract (Moringa oleifera extract)
  • Stevia rebaudiana Bertoni (Stevia rebaudiana)

Snippet

Sponsor: Yaounde Central Hospital | Conditions: Benefits of a Capsules of Moringa Oleifera and Stevia Rebaudiana Bertoni in Patients With Type 2 Diabetes Mellitus Before and After 45 Days of add-on Therapy | Phase 4 | Status: COMPLETED